KPG-0696S

N/A

Report date: 2025/01/26 18:38:06
NME

Base Information

Drug NameKPG-0696S
Drug Alias NameUbiquitin ligase modulator (Kangpu Biopharmaceutical)KPG-0696S
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin-protein ligases modulators
TargetsUbiquitin-protein ligases
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesKangpu Biopharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKangpu Biopharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A